Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction to: Melatonin at pharmacological concentrations suppresses osteoclastogenesis via the attenuation of intracellular ROS.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026

Same author

Efficacy of a WeChat mini-program-based self-management intervention for bipolar disorder: A randomized controlled trial.

Journal of affective disorders·2026

Same author

Gpnmb defines a phagocytic state of microglia linked to cell death in prion disease mouse model.

Nature communications·2026

Same author

Altered crosstalk of bacterial lipopolysaccharide with immune cells in colorectal cancer compared to paired adjacent intestinal tissue.

Gut microbes·2026

Same author

Dual-mechanism inhalable nanocomposite restores the alveolar mucus barrier and enables deep-lesion delivery for synergistic treatment of pulmonary fibrosis.

Journal of nanobiotechnology·2026

Same author

Prion propagation is controlled by a hierarchical network involving the nuclear Tfap2c and hnRNP K factors and the cytosolic mTORC1 complex.

PLoS pathogens·2026

Same journal

Julie Zikherman receives the ASCI/Marian W. Ropes, MD, Award.

The Journal of clinical investigation·2026

Same journal

Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models.

The Journal of clinical investigation·2026

Same journal

SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2.

The Journal of clinical investigation·2026

Same journal

MDM2 degraders for Merkel cell carcinoma: round peg in a round hole.

The Journal of clinical investigation·2026

Same journal

Ammonia in the crosshairs: microbial targets for metabolic dysfunction-associated steatohepatitis prevention.

The Journal of clinical investigation·2026

Same journal

Molecular mechanisms regulating cGAS/STING activation in health and disease.

The Journal of clinical investigation·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 26, 2026

Author Spotlight: Insight Into Advances in Prion Diseases Research

Author Spotlight: Insight Into Advances in Prion Diseases Research

Published on: August 11, 2023

Microglia in prion diseases.

Adriano Aguzzi, Caihong Zhu

The Journal of Clinical Investigation

|July 18, 2017

Summary

This summary is machine-generated.

Microglia, immune cells in the brain, may protect against prion diseases by clearing harmful proteins. Understanding their activation pathways is key for developing new neurodegenerative disorder treatments.

More Related Videos

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils

Published on: April 13, 2017

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

Related Experiment Videos

Last Updated: Feb 26, 2026

Author Spotlight: Insight Into Advances in Prion Diseases Research

Author Spotlight: Insight Into Advances in Prion Diseases Research

Published on: August 11, 2023

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils

Published on: April 13, 2017

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

Area of Science:

Neuroscience
Immunology
Pathology

Background:

Prion diseases are fatal neurodegenerative disorders caused by misfolded prion proteins (PrPSc) in the central nervous system (CNS).
Microglial activation is a hallmark of prion disease, alongside neuronal loss and spongiform changes.
The precise molecular mechanisms of microglial response to prion infection remain largely unknown.

Purpose of the Study:

To investigate the neuroprotective role of microglia in prion pathogenesis.
To explore the involvement of microglia-related molecules in prion disease.
To understand the regulatory network of microglial activation in prion infection.

Main Methods:

Review of existing literature on microglia and prion disease.
Analysis of molecular pathways involved in microglial activation (e.g., TLRs, complement system, cytokines).
Discussion of potential therapeutic strategies targeting microglial function.

Main Results:

Evidence suggests microglia may play an overall neuroprotective role in prion pathogenesis.
Various microglial molecules are implicated in prion disease progression.
A comprehensive understanding of microglial activation regulatory networks is lacking.

Conclusions:

Modulating microglial activation presents a promising therapeutic avenue for prion diseases.
Research into microglia in prion disease can enhance understanding of neuroinflammation in other neurodegenerative disorders.